Perkins Adelene Q 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-11+576,100→ 576,100 totalExercise: $1.53Exp: 2032-01-11→ Common Stock (576,100 underlying)
Footnotes (1)
- [F1]The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.